Gregory L. Krauss

12.7k total citations · 2 hit papers
153 papers, 7.6k citations indexed

About

Gregory L. Krauss is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Gregory L. Krauss has authored 153 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 128 papers in Psychiatry and Mental health, 81 papers in Pediatrics, Perinatology and Child Health and 58 papers in Cellular and Molecular Neuroscience. Recurrent topics in Gregory L. Krauss's work include Epilepsy research and treatment (126 papers), Pharmacological Effects and Toxicity Studies (72 papers) and Neuroscience and Neuropharmacology Research (55 papers). Gregory L. Krauss is often cited by papers focused on Epilepsy research and treatment (126 papers), Pharmacological Effects and Toxicity Studies (72 papers) and Neuroscience and Neuropharmacology Research (55 papers). Gregory L. Krauss collaborates with scholars based in United States, United Kingdom and Germany. Gregory L. Krauss's co-authors include Ronald P. Lesser, Michael R. Sperling, Mary A. Johnson, Jacqueline A. French, Neil R. Miller, Michela Gallagher, Marilyn Albert, Arnold Bakker, Caroline L. Speck and Antonio Laurenza and has published in prestigious journals such as Neuron, Brain and Neurology.

In The Last Decade

Gregory L. Krauss

150 papers receiving 7.3k citations

Hit Papers

Reduction of Hippocampal Hyperactivity Improves Cognition... 2012 2026 2016 2021 2012 2019 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Reduction of Hippocampal Hyperactivity Improves Cognition in Amnestic Mild Cognitive Impairment
    2012 672 citations Arnold Bakker, Gregory L. Krauss et al. Neuron profile →
  2. Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial
    2019 234 citations Gregory L. Krauss, Pavel Klein et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gregory L. Krauss United States 45 5.2k 3.6k 3.4k 1.5k 876 153 7.6k
Edward Faught United States 59 8.2k 1.6× 5.6k 1.6× 3.2k 0.9× 1.8k 1.2× 876 1.0× 187 10.2k
Frank Gilliam United States 57 8.2k 1.6× 5.3k 1.5× 2.9k 0.8× 2.1k 1.4× 784 0.9× 159 10.2k
Elinor Ben‐Menachem Sweden 52 6.1k 1.2× 5.0k 1.4× 3.3k 1.0× 1.4k 0.9× 1.1k 1.3× 149 9.2k
James W. Wheless United States 52 5.3k 1.0× 3.0k 0.8× 2.2k 0.6× 3.5k 2.3× 1.2k 1.4× 265 9.9k
Steven C. Schachter United States 43 3.9k 0.7× 2.1k 0.6× 2.3k 0.7× 2.7k 1.8× 1.1k 1.3× 193 8.0k
Bassel Abou‐Khalil United States 44 5.1k 1.0× 3.1k 0.9× 2.4k 0.7× 1.5k 1.0× 678 0.8× 204 6.8k
Pasquale Striano Italy 52 5.1k 1.0× 2.9k 0.8× 2.3k 0.7× 700 0.5× 1.6k 1.8× 478 10.4k
Bernhard J. Steinhoff Germany 44 4.5k 0.9× 2.9k 0.8× 2.6k 0.8× 1.7k 1.1× 1.2k 1.4× 219 7.5k
Cynthia L. Harden United States 46 4.2k 0.8× 2.9k 0.8× 1.5k 0.4× 984 0.7× 691 0.8× 161 6.3k
Marco Mula United Kingdom 44 5.4k 1.0× 3.4k 1.0× 1.6k 0.5× 1.0k 0.7× 407 0.5× 183 6.9k

Countries citing papers authored by Gregory L. Krauss

Since Specialization
Citations

This map shows the geographic impact of Gregory L. Krauss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory L. Krauss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory L. Krauss more than expected).

Fields of papers citing papers by Gregory L. Krauss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory L. Krauss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory L. Krauss. The network helps show where Gregory L. Krauss may publish in the future.

Co-authorship network of co-authors of Gregory L. Krauss

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory L. Krauss. A scholar is included among the top collaborators of Gregory L. Krauss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory L. Krauss. Gregory L. Krauss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krauss, Gregory L., Josemir W. Sander, & William E. Rosenfeld. (2025). Improving the tolerability of antiseizure medications: When and how to use cenobamate and other new antiseizure medications. Epilepsia. 66(S1). 15–28. 2 indexed citations
2.
Laxer, Kenneth D., Giancarlo Di Gennaro, Gregory L. Krauss, et al.. (2024). Presurgical Use of Cenobamate for Adult and Pediatric Patients Referred for Epilepsy Surgery: Expert Panel Recommendations. Neurology and Therapy. 13(5). 1337–1348. 6 indexed citations
3.
Krauss, Gregory L., et al.. (2023). Seizure Rescue Therapies: Comparing Approved and Commonly Used Benzodiazepine Formulations. Neurotherapeutics. 20(3). 758–766. 7 indexed citations
4.
Klein, Pavel, et al.. (2022). Dose Adjustment of Concomitant Antiseizure Medications During Cenobamate Treatment: Expert Opinion Consensus Recommendations. Neurology and Therapy. 11(4). 1705–1720. 47 indexed citations
5.
Rosenfeld, William E., Bassel Abou‐Khalil, Sami Aboumatar, et al.. (2021). Post hoc analysis of a phase 3, multicenter, open‐label study of cenobamate for treatment of uncontrolled focal seizures: Effects of dose adjustments of concomitant antiseizure medications. Epilepsia. 62(12). 3016–3028. 42 indexed citations
6.
Johnson, Emily L., Gregory L. Krauss, Anna Kucharska‐Newton, et al.. (2021). Mortality in Patients With Late-Onset Epilepsy. Neurology. 97(11). e1132–e1140. 15 indexed citations
7.
Sperling, Michael R., Bassel Abou‐Khalil, Sami Aboumatar, et al.. (2021). Efficacy of cenobamate for uncontrolled focal seizures: Post hoc analysis of a Phase 3, multicenter, open‐label study. Epilepsia. 62(12). 3005–3015. 40 indexed citations
8.
Rosenfeld, William E., Bassel Abou‐Khalil, Sami Aboumatar, et al.. (2021). Dose Adjustments to Concomitant Antiseizure Medications: Post-hoc Analysis of a Phase 3, Open-Label Study of Cenobamate for Treatment of Uncontrolled Focal Seizures (1755). Neurology. 96(15_supplement). 2 indexed citations
9.
Sperling, Michael R., Pavel Klein, Sami Aboumatar, et al.. (2020). Cenobamate (YKP3089) as adjunctive treatment for uncontrolled focal seizures in a large, phase 3, multicenter, open‐label safety study. Epilepsia. 61(6). 1099–1108. 142 indexed citations
10.
Johnson, Emily L., Gregory L. Krauss, Anna Kucharska‐Newton, et al.. (2020). Dementia in late-onset epilepsy. Neurology. 95(24). e3248–e3256. 60 indexed citations
11.
Klein, Pavel, Gregory L. Krauss, Sami Aboumatar, & Marc Kamin. (2020). Long-term Efficacy and Safety of Adjunctive Cenobamate in Patients With Uncontrolled Focal Seizures: Open-label Extension of a Randomized Clinical Study (1008). Neurology. 94(15_supplement). 10 indexed citations
12.
Rektor, Ivan, Gregory L. Krauss, Yushi Inoue, et al.. (2020). Assessment of the long‐term efficacy and safety of adjunctive perampanel in tonic‐clonic seizures: Analysis of four open‐label extension studies. Epilepsia. 61(7). 1491–1502. 15 indexed citations
13.
Johnson, Emily L., Gregory L. Krauss, Keenan A. Walker, et al.. (2020). Late‐onset epilepsy and 25‐year cognitive change: The Atherosclerosis Risk in Communities (ARIC) study. Epilepsia. 61(8). 1764–1773. 17 indexed citations
14.
Johnson, Emily L., Gregory L. Krauss, Alexandra K. Lee, et al.. (2019). Association between white matter hyperintensities, cortical volumes, and late-onset epilepsy. Neurology. 92(9). e988–e995. 33 indexed citations
15.
Krumholz, Allan, Jennifer L. Hopp, Perry J. Foreman, et al.. (2017). Regulating drivers with epilepsy in Maryland: Results of the application of a United States consensus guideline. Epilepsia. 58(8). 1389–1397. 13 indexed citations
16.
17.
18.
19.
Bakker, Arnold, Gregory L. Krauss, Marilyn Albert, et al.. (2012). Reduction of Hippocampal Hyperactivity Improves Cognition in Amnestic Mild Cognitive Impairment. Neuron. 74(3). 467–474. 672 indexed citations breakdown →
20.
Glauser, Tracy A., Gerhard Kluger, Rajesh Sachdeo, et al.. (2008). Rufinamide for generalized seizures associated with Lennox–Gastaut syndrome. Neurology. 70(21). 1950–1958. 272 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edward Faught Breakdown of academic impact, for papers by Frank Gilliam Breakdown of academic impact, for papers by Elinor Ben‐Menachem Breakdown of academic impact, for papers by James W. Wheless Breakdown of academic impact, for papers by Steven C. Schachter Breakdown of academic impact, for papers by Bassel Abou‐Khalil Breakdown of academic impact, for papers by Pasquale Striano Breakdown of academic impact, for papers by Bernhard J. Steinhoff Breakdown of academic impact, for papers by Cynthia L. Harden Breakdown of academic impact, for papers by Marco Mula
Rankless by CCL
2026